MEN1 and MEN2); ELL-PEN, Genes Proteins Oncogenes.">

Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ELL (eleven nineteen lysin rich leukemia gene)

Identity

Other namesMEN (myeloid eleven nineteen translocation: <-- WARNING: unrelated to MEN1 and MEN2); ELL-PEN
HGNC ELL
Location 19p13.1
Location_base_pair Starts at 18414473 and ends at 18493918 bp from pter ( according to hg18-Mar_2006).
Local_order proximal from LYL1 in 19p13.2-p13.1; ENL and E2A are more distal in 19p13.3

DNA/RNA

Transcription alternate splicing; 4.4 and 2.8 kb mRNA; coding sequence: 1.9 kb

Protein

Description 621 amino acids; 68 kDa; contains a Lysin rich domain (basic motif)
Expression wide; especially in leukocytes, muscle, testis, placenta
Localisation nuclear, except the nucleolus
Function RNA polymerase II elongation factor, promotes transcription by suppressing transient pausings. In Drosophila ELL is associated with active sites of transcription in vivo. Overexpression of ELL is toxic, suggesting the normal protein may play a role in the regulation of cell growth and survival.
Homology ELL2, ELL3

Implicated in

Entity t(11.19)(q23;p13.1) /ANLL --> MLL-ELL
Disease mainly M4/M5; treatment related leukemia; all ages
Prognosis very poor
Cytogenetics detected with R banding
Hybrid/Mutated Gene 5' MLL - 3' ELL
Abnormal Protein Similar to other MLL fusion proteins. The amino terminal AT hook and DNA methyltransferase homology regions from from MLL are fused to most of ELL
Oncogenesis The carboxyl terminal region of ELL is required for transformation by MLL-ELL in murine bone marrow transformation assays. This region has potent transcriptional activating activity, and interacts with EAF1, a protein that shares homology with AF4, LAF4, and AF5q31. Interestingly the EAF1 interacting domain, but not the ELL elongation domain is required for transformation. ELL has also been reported to interact withp53 and inhibit its transcriptional activating activity.
  

External links

Nomenclature
HGNCELL   23114
Entrez_GeneELL  8178  elongation factor RNA polymerase II
Cards
AtlasELL
GeneCardsELL
EnsemblELL [Search_View]   ENSG00000105656 [Gene_View]  ELL [Vega]
GenatlasELL
GeneLynxELL
eGenomeELL
euGene8178
Genomic and cartography
GoldenPathELL  -  19p13.1   chr19:18414473-18493918 -  19p13.1   [Description]    (hg18-Mar_2006)
EnsemblELL - 19p13.1 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneELL
Gene and transcription
GenbankAB208794 [ ENTREZ ]
GenbankAF157562 [ ENTREZ ]
GenbankAK225481 [ ENTREZ ]
GenbankAK293105 [ ENTREZ ]
GenbankAK309878 [ ENTREZ ]
RefSeqNM_006532 [ SRS ]    NM_006532 [ ENTREZ ]
RefSeqAC_000062 [ SRS ]    AC_000062 [ ENTREZ ]
RefSeqAC_000151 [ SRS ]    AC_000151 [ ENTREZ ]
RefSeqNC_000019 [ SRS ]    NC_000019 [ ENTREZ ]
RefSeqNT_011295 [ SRS ]    NT_011295 [ ENTREZ ]
RefSeqNW_001838484 [ SRS ]    NW_001838484 [ ENTREZ ]
RefSeqNW_927195 [ SRS ]    NW_927195 [ ENTREZ ]
CCDSELL CCDS - NCBI
AceViewELL AceView - NCBI
UnigeneHs.515260 [ SRS ]    Hs.515260 [ NCBI ]     HS515260 [ spliceNest ]
Fast-db9127 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP55199 [ SRS]    P55199 [ EXPASY ]     P55199 [ INTERPRO ]     P55199 [ UNIPROT ] P55199 [ VarSplice ]
InterproIPR010844 Occludin_ELL [ SRS ]    IPR010844 Occludin_ELL [ EBI ]
CluSTrP55199
PfamPF07303 Occludin_ELL [ SRS ]    PF07303 Occludin_ELL [ Sanger ]    pfam07303 [ NCBI-CDD ]
BlocksP55199
PDB2DOA [ SRS ]    2DOA [ PdbSum ],   2DOA [ IMB ]   2DOA [ RSDB ]
HPRD02615
Protein Interaction databases
DIPP55199
IntActP55199
Polymorphism : SNP, mutations, diseases
OMIM600284    [ map ]   
GENECLINICS600284
SNPELL [dbSNP-NCBI]  
SNPNM_006532 [SNP-NCI]  
SNPELL [GeneSNPs - Utah]  ELL] [HGBASE - SRS]
HAPMAPELL [HAPMAP]  
COSMICELL [Somatic mutation (COSMIC-CGP-Sanger)]  
TICdbELL [Translocation breakpoints In Cancer]  
HGMDELL
Genetic AssociationELL
CDC HuGEELL
General knowledge
Family BrowserELL [UCSC Family Browser]
SOURCENM_006532
SMDHs.515260
SAGEHs.515260
GOprotein binding [Amigo]  protein binding
GOnucleus [Amigo]  nucleus
GOnucleoplasm [Amigo]  nucleoplasm
GOtranscription [Amigo]  transcription
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GORNA elongation from RNA polymerase II promoter [Amigo]  RNA elongation from RNA polymerase II promoter
GOpositive transcription elongation factor activity [Amigo]  positive transcription elongation factor activity
GOnuclear speck [Amigo]  nuclear speck
PubGeneELL
TreeFamELL
CTD8178 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeELL Related clones (RZPD - Berlin)
PubMed
PubMed25 Pubmed reference(s) in Entrez

Bibliography

Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD
Proceedings of the National Academy of Sciences of the United States of America. 1994 ; 91 (25) : 12110-12114.
PMID 7991593
 
Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation.
Mitani K, Kanda Y, Ogawa S, Tanaka T, Inazawa J, Yazaki Y, Hirai H
Blood. 1995 ; 85 (8) : 2017-2024.
PMID 7718874
 
An RNA polymerase II elongation factor encoded by the human ELL gene.
Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW
Science (New York, N.Y.). 1996 ; 271 (5257) : 1873-1876.
PMID 8596958
 
Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
Shilatifard A, Haque D, Conaway RC, Conaway JW
The Journal of biological chemistry. 1997 ; 272 (35) : 22355-22363.
PMID 9268387
 
Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia.
Maki K, Mitani K, Yamagata T, Kurokawa M, Kanda Y, Yazaki Y, Hirai H
Blood. 1999 ; 93 (10) : 3216-3224.
PMID 10233872
 
Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3.
Miller T, Williams K, Johnstone RW, Shilatifard A
The Journal of biological chemistry. 2000 ; 275 (41) : 32052-32056.
PMID 10882741
 
A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A
Blood. 2000 ; 96 (12) : 3887-3893.
PMID 11090074
 
Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.
Gerber M, Ma J, Dean K, Eissenberg JC, Shilatifard A
The EMBO journal. 2001 ; 20 (21) : 6104-6114.
PMID 11689450
 
Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.
Johnstone RW, Gerber M, Landewe T, Tollefson A, Wold WS, Shilatifard A
Molecular and cellular biology. 2001 ; 21 (5) : 1672-1681.
PMID 11238904
 
EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ
Blood. 2001 ; 98 (1) : 201-209.
PMID 11418481
 
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ
Molecular and cellular biology. 2001 ; 21 (16) : 5678-5687.
PMID 11463848
 
MEN1%20and%20MEN2);%20ELL-PEN%5BTI%5D%20)%20AND%20REVIEW%5BPT%5D%20AND%20ENGLISH%5BLA%5D&field=titl&dispmax=50>REVIEW articlesautomatic search in PubMed
MEN1%20and%20MEN2);%20ELL-PEN%5BTI%5D%20)%20AND%20(2006%5BDP%5D%20OR%202007%20OR%202008%5BDP%5D)&field=titl&dispmax=50>Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written12-1997Jean-Loup Huret
Updated04-2003Jay L. Hess

Citation

This paper should be referenced as such :
Huret JL . ELL (eleven nineteen lysin rich leukemia gene). Atlas Genet Cytogenet Oncol Haematol. December 1997 .
URL : http://AtlasGeneticsOncology.org/Genes/ELL.html
Hess JL . ELL (eleven nineteen lysin rich leukemia gene). Atlas Genet Cytogenet Oncol Haematol. April 2003 .
URL : http://AtlasGeneticsOncology.org/Genes/ELL.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sun Nov 9 19:40:03 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.